← FDA Drug Approvals (Drugs@FDA)

LACOSAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2023-12-22

Drug application

FDA Application #

ANDA215379

Application type

Abbreviated New Drug Application (Generic)

Brand name

LACOSAMIDE

Generic name

LACOSAMIDE

Active ingredients

LACOSAMIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

Manufacturer

Glenmark Pharmaceuticals Limited

First approval

2023-12-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown